2008 annual financial data
Alnylam Pharmaceuticals 2008 Operating margin
Direct answer
Operating margin was -28.95%.
Operating income was -27,835,000 USD and net income was -26,249,000 USD.
Operating cash flow was 65,491,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 96,163,000 USD
- Operating income
- -27,835,000 USD
- Net income
- -26,249,000 USD
- Operating cash flow
- 65,491,000 USD